Manufacturers Life Insurance Company, The Bei Gene, Ltd. Transaction History

Manufacturers Life Insurance Company, The

  • $109 Billion
  • Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 59,831 shares of BGNE stock, worth $13.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
59,831
Previous 57,384 4.26%
Holding current value
$13.6 Million
Previous $12.9 Million 14.22%
% of portfolio
0.01%
Previous 0.01%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$174.72 - $246.04 $427,539 - $602,059
2,447 Added 4.26%
59,831 $11.1 Million
Q3 2024

Nov 13, 2024
BUY
$143.93 - $224.51 $1.03 Million - $1.6 Million
7,122 Added 14.17%
57,384 $12.9 Million
Q2 2024

Aug 14, 2024
BUY
$129.52 - $174.32 $507,070 - $682,462
3,915 Added 8.45%
50,262 $7.17 Million
Q1 2024

May 14, 2024
BUY
$141.8 - $181.47 $934,178 - $1.2 Million
6,588 Added 16.57%
46,347 $7.25 Million
Q4 2023

Feb 13, 2024
BUY
$158.67 - $201.58 $841,585 - $1.07 Million
5,304 Added 15.39%
39,759 $7.17 Million
Q3 2023

Nov 15, 2023
BUY
$179.87 - $225.13 $167,638 - $209,821
932 Added 2.78%
34,455 $6.2 Million
Q2 2023

Aug 11, 2023
BUY
$178.3 - $266.78 $2.64 Million - $3.95 Million
14,815 Added 79.19%
33,523 $5.98 Million
Q1 2023

May 15, 2023
BUY
$215.53 - $274.5 $764,484 - $973,651
3,547 Added 18.96%
22,255 $4.8 Million
Q4 2022

Aug 11, 2023
SELL
$125.51 - $229.3 $111,578 - $203,847
-889 Reduced 4.54%
18,708 $4.11 Million
Q4 2022

Feb 13, 2023
SELL
$125.51 - $229.3 $111,578 - $203,847
-889 Reduced 4.54%
18,708 $4.11 Million
Q3 2022

Aug 11, 2023
SELL
$131.8 - $202.24 $197,700 - $303,360
-1,500 Reduced 7.11%
19,597 $2.64 Million
Q3 2022

Nov 03, 2022
SELL
$131.8 - $202.24 $197,700 - $303,360
-1,500 Reduced 7.11%
19,597 $2.66 Million
Q2 2022

Aug 11, 2023
BUY
$121.11 - $216.05 $111,663 - $199,198
922 Added 4.57%
21,097 $3.41 Million
Q2 2022

Aug 15, 2022
BUY
$121.11 - $216.05 $111,663 - $199,198
922 Added 4.57%
21,097 $3.42 Million
Q1 2022

Aug 11, 2023
SELL
$146.52 - $269.56 $304,761 - $560,684
-2,080 Reduced 9.35%
20,175 $3.81 Million
Q1 2022

May 20, 2022
BUY
$146.52 - $269.56 $1.8 Million - $3.31 Million
12,275 Added 155.38%
20,175 $4.01 Million
Q4 2021

Feb 16, 2022
SELL
$248.56 - $389.34 $99,424 - $155,736
-400 Reduced 4.82%
7,900 $2.15 Million
Q3 2021

Nov 12, 2021
BUY
$249.6 - $403.14 $199,680 - $322,512
800 Added 10.67%
8,300 $3.01 Million
Q2 2021

Aug 12, 2021
SELL
$292.75 - $367.01 $29,275 - $36,701
-100 Reduced 1.32%
7,500 $2.57 Million
Q1 2021

May 03, 2021
SELL
$260.64 - $382.12 $182,448 - $267,484
-700 Reduced 8.43%
7,600 $2.65 Million
Q4 2020

Feb 12, 2021
SELL
$221.31 - $316.61 $1.48 Million - $2.11 Million
-6,678 Reduced 44.59%
8,300 $2.15 Million
Q3 2020

Nov 09, 2020
SELL
$189.18 - $286.44 $1.01 Million - $1.52 Million
-5,322 Reduced 26.22%
14,978 $4.29 Million
Q2 2020

Aug 10, 2020
BUY
$123.9 - $195.41 $669,060 - $1.06 Million
5,400 Added 36.24%
20,300 $3.84 Million
Q1 2020

May 15, 2020
SELL
$121.84 - $173.19 $15.9 Million - $22.6 Million
-130,316 Reduced 89.74%
14,900 $1.84 Million
Q4 2019

Feb 14, 2020
SELL
$115.78 - $208.34 $9.35 Million - $16.8 Million
-80,786 Reduced 35.75%
145,216 $24.1 Million
Q3 2019

Nov 12, 2019
SELL
$120.61 - $148.29 $1.11 Million - $1.36 Million
-9,172 Reduced 3.9%
226,002 $27.5 Million
Q2 2019

Aug 14, 2019
BUY
$113.99 - $146.86 $19.4 Million - $25 Million
170,412 Added 263.14%
235,174 $29.2 Million
Q1 2019

May 13, 2019
SELL
$122.82 - $151.83 $1.46 Million - $1.81 Million
-11,925 Reduced 15.55%
64,762 $8.55 Million
Q4 2018

Feb 14, 2019
BUY
$107.01 - $175.15 $848,268 - $1.39 Million
7,927 Added 11.53%
76,687 $10.8 Million
Q3 2018

Nov 14, 2018
SELL
$152.62 - $189.66 $5.88 Million - $7.3 Million
-38,515 Reduced 35.9%
68,760 $11.8 Million
Q2 2018

Aug 14, 2018
BUY
$152.5 - $216.77 $6.55 Million - $9.31 Million
42,936 Added 66.73%
107,275 $16.5 Million
Q1 2018

May 15, 2018
SELL
$97.41 - $177.22 $2.05 Million - $3.74 Million
-21,094 Reduced 24.69%
64,339 $10.8 Million
Q4 2017

Feb 08, 2018
SELL
$79.6 - $114.73 $756,200 - $1.09 Million
-9,500 Reduced 10.01%
85,433 $8.35 Million
Q3 2017

Nov 14, 2017
BUY
$66.19 - $103.46 $6.28 Million - $9.82 Million
94,933
94,933 $9.82 Million

Others Institutions Holding BGNE

# of Institutions
254
Shares Held
42.4M
Call Options Held
135K
Put Options Held
111K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $23.5B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email